Full Year 2023 Pro Medicus Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Pro Medicus Limited Full Year Results Briefing. (Operator Instructions) I would now like to hand the conference over to Dr. Sam Hupert, CEO. Please go ahead.
Thanks. Good morning, everybody, and thanks for joining us. As most of you know, we are a healthcare IT company specializing in imaging and radiology information systems. We work in 3 jurisdictions, Melbourne, our corporate office and where we developed the RIS product; Berlin, which is our development center for Visage; and U.S., which is a key market.
We have 2 product sets. I won't labor too long on this. The [RIS], which is largely Australian-focused, more around the business side of radiology; and Visage 7, which is a clinical product. It's the desktop [radials] which use [to call up] images, enhance them and make a diagnosis, and it's the product we sell -- product set that we sell in the U.S.
In terms of the year, just a few highlights. It was a record
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |